This inventor holds 1 USPTO granted patent. Top assignee: Gritgen Therapeutics Limited. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Xihuimin Dai: Innovator in Nucleic Acid Technology
Introduction
Xihuimin Dai is a prominent inventor based in Beijing, China. He has made significant contributions to the field of biotechnology, particularly in the area of nucleic acid research. His innovative work has led to the development of valuable patents that advance scientific understanding and applications.
Latest Patents
Xihuimin Dai holds a patent for an "Isolated Nucleic Acid Molecule and Application Thereof." This patent represents a crucial advancement in the field, showcasing his expertise and commitment to innovation. The patent is a testament to his ability to create solutions that can have a lasting impact on biotechnology.
Career Highlights
Dai is currently associated with Gritgen Therapeutics Limited, where he continues to push the boundaries of research and development. His work at Gritgen Therapeutics Limited focuses on harnessing the potential of nucleic acids for therapeutic applications. With a patent portfolio that includes 1 patent, he has established himself as a key player in the industry.
Collaborations
Throughout his career, Xihuimin Dai has collaborated with talented individuals such as Enxing Zhou and Yuan Liu. These partnerships have fostered a collaborative environment that enhances innovation and drives research forward.
Conclusion
Xihuimin Dai's contributions to nucleic acid technology exemplify the spirit of innovation in biotechnology. His work not only advances scientific knowledge but also paves the way for future developments in the field.